Podcasts about Inflammatory bowel disease

A look at Inflammatory Bowel Disease (IBD), more specifically the two main forms of IBD which are Ulcerative Colitis and Crohn's Disease, going through each condition as well as looking at the differences between Ulcerative Colitis and Crohn's disease. Includes the signs and symptoms of each, including extraintestinal manifestations of inflammatory bowel disease, as well as differences in the histology. PDFs available at: https://rhesusmedicine.com/pages/gastroenterologyConsider subscribing (if you found any of the info useful!): https://www.youtube.com/channel/UCRks8wB6vgz0E7buP0L_5RQ?sub_confirmation=1Buy Us A Coffee!: https://www.buymeacoffee.com/rhesusmedicineTimestamps:0:00 What is Inflammatory Bowel Disease?0:15 Ulcerative Colitis and Crohn's Disease Epidemiology1:08 Signs and Symptoms of Inflammatory Bowel Disease / Signs and Symptoms of Ulcerative Colitis and Crohn's Disease3:19 Extraintestinal Manifestations of Inflammatory Bowel Disease4:48 Inflammatory Bowel Disease Pathology5:07 Risk Factors for Ulcerative Colitis and Crohn's Disease / Risk Factors of Inflammatory Bowel Disease5:47 Diagnosis of Ulcerative Colitis and Crohn's Disease / Inflammatory Bowel Disease Diagnosis6:51 Inflammatory Bowel Disease Histology / Ulcerative Colitis v Crohn's Disease Histology7:52 Treatment of Inflammatory Bowel Disease / Ulcerative Colitis and Crohn's Disease TreatmentLINK TO SOCIAL MEDIA: https://www.instagram.com/rhesusmedicine/ReferencesCrohn's & Colitis Foundation (2019) Updated IBD Factbook. Crohn's & Colitis Foundation. Available at: https://www.Crohn'scolitisfoundation.org/sites/default/files/2019-02/Updated%20IBD%20Factbook.pdfWalfish, A.E. and Ching Companioni, R.A. (2023) ‘Overview of inflammatory bowel disease', MSD Manual Professional Edition. Merck & Co., Inc. Available at: https://www.msdmanuals.com/professional/gastrointestinal-disorders/inflammatory-bowel-disease-ibd/overview-of-inflammatory-bowel-diseaseWaugh, N., Cummins, E., Royle, P. et al. (2013) Comparison of Ulcerative Colitis, Crohn's disease, irritable bowel syndrome and coeliac disease, in Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation. Southampton: NIHR Journals Library. Available at: https://www.ncbi.nlm.nih.gov/books/NBK261307/Disclaimer: Please remember this video and all content from Rhesus Medicine is for educational and entertainment purposes only and is not a guide to diagnose or to treat any form of condition. The content is not to be used to guide clinical practice and is not medical advice. Please consult a healthcare professional for medical advice.

Send us a textIBD & Hair loss ~ are they connected? Anna Mitchell is a Trichologist with a clinic in Hastings.Her sister was born when she was 7 years old, and she had two different types of alopecia; this meant, as a child, numerous visits to the doctor, and to a trichologist, who was very nice and helpful at the time. This meant that Anna was introduced to the industry at a very young age.She has always been a curious person, wanting to know why things are happening, and how they manifest. Anna herself suffers from Inflammatory bowel disease, and she shares how she is one of 1/2 a million with the condition. She uncovers the large variety of symptoms, and describes this as an invisible illness, due to the fact that it isn't spoken about openly.She shares her knowledge on the autoimmune condition, along with her own personal experience, and explains how this can have an impact on hair health.Connect with Anna:InstagramWebsite Hair & Scalp Salon Specialist course Support the showConnect with Hair therapy: Facebook Instagram Twitter Clubhouse- @Hair.Therapy Donate towards the podcast Start your own podcastHair & Scalp Salon Specialist Course ~ Book now to become an expert!

Send us a textWhat does great IBD care look like when the system won't make it easy? We sit down with Dr. Adam Ehrlich, Section Chief of Gastroenterology at Temple Health and GI fellowship program director, to explore how he builds patient-centered care in an underserved setting—where insurance denials, missing records, and real-life logistics collide with complex disease.We talk about health literacy, trust, and the conversations that actually change outcomes. Adam explains how he frames risks and benefits with clarity, why the “risks of doing nothing” deserve equal airtime, and how he balances mode of therapy—IV, subcutaneous, or oral—against lifestyle, trauma history, pregnancy plans, and coverage rules. We dig into prison medicine's constraints, from medication access to policy barriers around scheduling, and the creative problem-solving required to keep patients safe and informed. He shares why being honest about uncertainty builds credibility, and how an early investment in patient education pays off with better monitoring and shared targets for remission.The episode also gets practical about personalization. We discuss drug levels with infliximab when severe colitis “loses” medication into the stool, when it's wise to de-escalate dosing, and how habits from flare days can persist after inflammation settles. Adam offers tools to retrain routines, navigate IBS overlap, and align care with quality of life goals like driving, work travel, and showing up at a kid's soccer game without anxiety. As a fellowship director, he reveals how he equips new gastroenterologists to handle today's broader therapy menu, think beyond flowcharts, and advocate through insurance barriers with persistence and purpose.If this conversation resonates, tap follow, share it with someone who needs it, and leave a quick review. Your support helps more people find practical, human-centered IBD care.Links and organizations to follow! Color of Gastrointestinal Illness (COGI)- mission to improve quality of life for BIPOC who are affected by IBD and other GI issues. The Stephanie A. Wynn Foundation - mission to eliminate health disparities and improve outcomes for individuals and communities affected by Inflammatory Bowel Diseases through comprehensive support services, with priority given to underserved populations facing the greatest barriers to healthcare.Strategic Alliance for Intercultural Advocacy in GI (SAIA)- mission to create culturally sensitive resources, research, and education for patients, caregivers and healthcare providers managing chronic GI conditions in order to minimize delays, dispel stigma, promote early diagnosis, and improve access to treatment for all.Let's get social!!Follow us on Instagram!Follow us on Facebook!Follow us on Twitter!

The gut microbiome is more than just bacteria. It encompasses all organisms and genetic material including yeast, viruses, and archaea. It is a common belief that yeast in the GI tract needs to be eradicated. But not so fast. In this episode, we focus on the mycobiome. We examine the dual roles of commensal and pathogenic yeast species within the GI tract, exploring how they influence immune signaling, metabolic function, and mucosal integrity. We also discuss emerging evidence linking fungal dysbiosis to conditions such as Inflammatory Bowel Disease, cancer, and systemic inflammation. If you’re interested in the clinical science behind how yeast can support health – or contribute to disease - this episode explores a topic often overlooked in longevity medicine. Today on The Lab Report: 4:00 The Gut Mycobiome – needs a new name 6:40 Yeast vs. Bacteria 9:00 Development of the commensal mycobiome 11:00 The important role of yeast & their metabolites 15:25 Candida and Malassezia 18:45 Saccharomyces 21:05 Dietary influences and fermented foods 23:30 Question of the Day If yeast grows out in culture on the GI Effects, what next? Additional Resources: GI Effects Stool Profile Microbiomix Subscribe, Rate, & Review The Lab Report Thanks for tuning in to this week’s episode of The Lab Report, presented by Genova Diagnostics, with your hosts Michael Chapman and Patti Devers. If you enjoyed this episode, please hit the subscribe button and give us a rating or leave a review. Don’t forget to visit our website, like us on Facebook, follow us on Twitter, Instagram, and LinkedIn. Email Patti and Michael with your most interesting and pressing questions on functional medicine: podcast@gdx.net. And, be sure to share your favorite Lab Report episodes with your friends and colleagues on social media to help others learn more about Genova and all things related to functional medicine and specialty lab testing. To find a qualified healthcare provider to connect you with Genova testing, or to access select products directly yourself, visit Genova Connect. Disclaimer: The content and information shared in The Lab Report is for educational purposes only and should not be taken as medical advice. The views and opinions expressed in The Lab Report represent the opinions and views of Michael Chapman and Patti Devers and their guests.See omnystudio.com/listener for privacy information.

nflammatory Bowel Disease (IBD) can be challenging to treat; however, when effective self-care strategies are employed, there is better disease management and higher quality of life. On this show, Karolyn talks with gastrointestinal expert and educator Mark Davis, ND, about how people with IBD can better manage their condition. Dr. Davis specializes in the treatment of IBD and also teaches other healthcare professionals about the value of an integrative approach to IBD treatment and self-care.Five To Thrive Live is broadcast live Tuesdays at 7PM ET and Music on W4CS Radio – The Cancer Support Network (www.w4cy.com) part of Talk 4 Radio (www.talk4radio.com) on the Talk 4 Media Network (www.talk4media.com).Five To Thrive Live Podcast is also available on Talk 4 Media (www.talk4media.com), Talk 4 Podcasting (www.talk4podcasting.com), iHeartRadio, Amazon Music, Pandora, Spotify, Audible, and over 100 other podcast outlets.

“Within three days, we went from almost bankrupt… to one of the stars of the Nasdaq.”In this conversation, I take you behind the scenes of a biotech journey that sounds almost unbelievable.Marc de Garidel, CEO of Abivax, tells me how he rebuilt this French biotech from scratch, designed a strategy powerful enough to attract top US investors and executed one of the largest phase 3 programs in ulcerative colitis: a molecule from French public research (CNRS, Institut Curie and the University of Montpellier) which may have a major impact on patients.This episode is a masterclass in leadership, execution, courage, and long-term thinking.Here's what you'll hear about in this episode:◾️ How Marc stepped into a company with almost no long-term plan… and why that turned out to be a surprising advantage.◾️ The four pillars of a new strategy — and how one of them quietly set the stage for the breakthrough to come.◾️ What it really takes to run a global phase 3 across dozens of countries — and why Abivax had to reinvent itself to pull it off.◾️ A mechanism of action unlike anything else in IBD — and why this difference matters more than most people think.◾️ The hidden lessons from a noisy phase 2 that helped transform the phase 3 into something no one saw coming.◾️ A leadership philosophy built on transparency and speed, born from a single principle: in biotech, every day counts.◾️ The unexpected market reaction that changed the fate of the company overnight — with numbers that almost don't seem real.If you want to hear a real behind-the-scenes story, hit play.This episode is an exceptional inside look at what it truly takes to turn science into impact, stand your ground under pressure, and lead a biotech from survival… to breakthrough.—Find Marc de Garidel:LinkedIn: https://www.linkedin.com/in/marc-de-garidel-097982/—Resources mentioned in the episode:Abivax https://www.abivax.com/Pharma Minds episodes mentioned:His first interview in Pharma Minds in 2023: “CEO Marc De Garidel On Building Something Truly Impactful: Embrace Risks!” https://www.youtube.com/watch?v=mA3-OSltbwQ (in English)—

In this preview, Marc de Garidel, CEO of Abivax, shares the moment a phase 3 trial delivered results far beyond expectations — a rare scientific milestone that triggered an intense 48-hour sprint and a record-breaking stock surge.

Send us a textThe hardest part isn't always the pain; it's the fog—those days when the labels keep changing, the meds blur together, and the bills are louder than your body. That's where Stephanie A. Wynn stepped in, transforming her Crohn's journey into a movement for clarity, access, and equity.We sit down with Stephanie—author, podcaster, and founder of the Stephanie A. Wynn Foundation—to unpack how a misdiagnosis spiral, two heartbreaking pregnancy losses, and a sixth GI finally led to answers and action. She walks us through the IBD Patient Navigator Program she built to connect people with the care team they actually need: GI, primary care, mental health, dietitian, pelvic floor therapist, and, when needed, a colorectal surgeon. We talk about practical tools that change outcomes—recording appointments, coming with three priority questions, tracking symptoms and meals, and learning your labs so they can become signals instead of mysteries.Stephanie also opens up her book Navigating IBD: A Six-Week Blueprint for Better Gut Health which she designed to slow overwhelm and teach the language of care including treatment decisions, and what “knowing your numbers” truly means. We dig into clinical trials—why she calls it clinical research, how to qualify, what to ask about aftercare, and ways to participate through labs or tissue samples to boost representation. We tackle health disparities and social determinants of health head-on: transportation, refrigeration for meds, school support, and why trust is built by showing up with real solutions.This is a conversation about agency and community for anyone living with Crohn's disease or ulcerative colitis. You'll leave with a sharper checklist, a stronger voice, and a reminder that you are not alone—and that the right tools and team can change everything.If this helped you, follow the show, leave a quick review, and share it with someone who needs a clear path forward today.Links: Link to Stephanie's IBD bookThe Stephanie A. Wynn FoundationRacial and Ethnic Disparities in Medical Advancements and Technologies- Kaiser Family Foundation Let's get social!!Follow us on Instagram!Follow us on Facebook!Follow us on Twitter!

After 6 years of hosting The One Thing Podcast and 20 years in clinical practice, I'm thrilled to announce my first group program: The Gut Freedom Intensive.This is a 6-week cohort-based course that brings my one-on-one clinical approach to a small group format. If you've been struggling with IBS, SIBO, Inflammatory Bowel Disease, bloating, or any form of digestive distress, this intensive is designed for you.What You'll Get:6 weekly live group sessions with mePersonalized roadmap for your specific digestive imbalancesDeep dives into gut immunity, microbiome, food sensitivities, and moreInteractive assignments to identify YOUR root causesGuidance on nutrition, lifestyle, supplements, and functional testingOngoing support throughout the programThis isn't a one-size-fits-all approach. Through guided exercises and assessments, we'll uncover exactly what YOUR gut needs to heal.Course Details:Starts: February 4th, 2026Duration: 6 weeksFormat: Live weekly sessions + comprehensive curriculumLimited to 25 participantsSpecial Listener Discount: Listen to the special announcement where I mention a code that will give a discount of 20% off - good through December 15th, 2025Enroll at: [Gut Freedom Intensive]Questions? email support@soundintegrative.com I look forward to guiding you on your journey to gut freedom.Show Notes:

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/WDQ865. CME/AAPA credit will be available until November 25, 2026.Fibrosis, Flares, and Forward Thinking in Inflammatory Bowel Disease Care: Unlocking the TL1A Axis In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Genentech, a member of the Roche Group and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/WDQ865. CME/AAPA credit will be available until November 25, 2026.Fibrosis, Flares, and Forward Thinking in Inflammatory Bowel Disease Care: Unlocking the TL1A Axis In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Genentech, a member of the Roche Group and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/WDQ865. CME/AAPA credit will be available until November 25, 2026.Fibrosis, Flares, and Forward Thinking in Inflammatory Bowel Disease Care: Unlocking the TL1A Axis In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Genentech, a member of the Roche Group and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/WDQ865. CME/AAPA credit will be available until November 25, 2026.Fibrosis, Flares, and Forward Thinking in Inflammatory Bowel Disease Care: Unlocking the TL1A Axis In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Genentech, a member of the Roche Group and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/WDQ865. CME/AAPA credit will be available until November 25, 2026.Fibrosis, Flares, and Forward Thinking in Inflammatory Bowel Disease Care: Unlocking the TL1A Axis In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Genentech, a member of the Roche Group and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/WDQ865. CME/AAPA credit will be available until November 25, 2026.Fibrosis, Flares, and Forward Thinking in Inflammatory Bowel Disease Care: Unlocking the TL1A Axis In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Genentech, a member of the Roche Group and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/WDQ865. CME/AAPA credit will be available until November 25, 2026.Fibrosis, Flares, and Forward Thinking in Inflammatory Bowel Disease Care: Unlocking the TL1A Axis In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Genentech, a member of the Roche Group and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/WDQ865. CME/AAPA credit will be available until November 25, 2026.Fibrosis, Flares, and Forward Thinking in Inflammatory Bowel Disease Care: Unlocking the TL1A Axis In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Genentech, a member of the Roche Group and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

Send us a textWelcome to episode 1 of our series- IBD Can Eat Me guest hosted by Stacey Collins, IBD RD. In this series, Stacey will interview other Dietitians who also specialize in IBD. This week we welcomed Venus Kalami- board-certified pediatric Dietitian Nutritionist! What if the strict diet you're told to follow does more harm than good? We sit down with pediatric dietitian Venus to unpack how nutrition in IBD can support health without sacrificing joy, culture, or family life. From Stanford Children's IBD and celiac center to medical affairs and public education, Venus brings a rare mix of clinical depth and human warmth—and she doesn't shy away from hard truths.We dig into the pressure families feel to “do everything,” the overuse of restrictive therapeutic diets, and the real risks that come with them: malnutrition, ARFID, pediatric feeding disorders, and lasting food trauma. Venus shares a clear way to tell the difference between a transient food reaction and an inflammatory flare, helping patients step off the rollercoaster of fear and over-correction. She also shows how to make care culturally inclusive with simple, powerful questions: What do you like? What do you cook? What feels doable at home? It's a move from generic handouts to plans that honor heritage foods and real life.You'll hear a vivid case study where a patient referred for low FODMAP improved dramatically without elimination—just lactase with dairy, spreading fruit across the day, and changing other patterns developed from past food trauma. We talk about involving mental health early, “asking around the ask” when supplements come up, and borrowing pediatric best practices for adults who shouldn't have to navigate IBD alone. The theme running through it all: patients deserve permission to dream beyond survival. Biomarkers matter, but so do birthdays, travel, and the comfort foods that make you feel at home.If this conversation resonates, follow the show, share it with someone who needs a gentler path, and leave a review to help more people find evidence-based, humane IBD care. Your feedback shapes future episodes—what question should we tackle next?Nutrition Pearls podcast with VenusVenus on XSolid Starts app"Offering Nutritional Therapies to Patients with IBD: Even If You're Not An Expert"- Video from Nutritional Therapy for IBDLet's get social!!Follow us on Instagram!Follow us on Facebook!Follow us on Twitter!

Send us a textWant a clear, human guide to modern IBD care without the jargon? We're joined by Janette Villalon, a physician assistant at UC Irvine's IBD Center, who brings a front-line view of what truly helps patients: personalized therapy choices, honest safety talk, and practical plans that fit real life. She traces the evolution from a handful of anti-TNFs to a wider toolkit—anti-integrins, IL-12/23 and IL-23 inhibitors, JAK inhibitors, and S1P modulators—and explains how we match treatments to goals like fast relief, fewer side effects, and coverage of extraintestinal issues such as arthritis, uveitis, and psoriasis.We dig into how APPs power the day-to-day of IBD clinics, from education to monitoring and rapid access, and how the GHAPP Conference and national societies elevated advanced practice training. Janette breaks down when clinical trials make sense, why strict inclusion criteria matter, and how logistics can steer decisions when someone is very sick. She demystifies biosimilars, outlining FDA standards that support confident switches when insurance demands it, and shares how she helps patients balance infusions, injections, or pills against travel, work, and adherence.For those planning a family, Janette offers timely guidance: aim for clinical and endoscopic remission three to six months before conception, continue pregnancy-safe maintenance therapy, and discuss starting low-dose aspirin at 12 to 16 weeks to lower preeclampsia risk, coordinated with maternal-fetal medicine.Looking ahead, we explore precision medicine and AI—predictive markers, microbiome insights, and smarter monitoring that could reduce trial-and-error and catch flares early. The throughline is empowerment: ask questions, read, return for follow-ups, and shape your care around your life. We close with community resources from the Crohn's & Colitis Foundation and a shout-out to Camp Oasis for young patients.If this conversation helped you, subscribe, share it with a friend, and leave a quick review—what's the one topic you want us to go deeper on next?Links: Gastroenterology & Hepatology Advanced Practice Providers (GHAPP) organization Camp Oasis- Crohn's & Colitis Foundation USAIBD Medication Guide- Crohn's & Colitis Foundation USAPregnancy & IBD video- Crohn's & Colitis Foundation USALet's get social!!Follow us on Instagram!Follow us on Facebook!Follow us on Twitter!

In this week's episode, we sit down with Dane Johnson, founder of the Crohn's & Colitis Lifestyle, who went from near rock-bottom with IBD to building a thriving system for full-body healing. Dane shares how he transformed years of pain and confusion into purpose—by becoming the CEO of his own health. We talk about the exact tools and mindset shifts that helped him rebuild his microbiome, restore his nervous system, and rediscover hope when conventional medicine fell short. Whether you're battling IBD or simply ready to take radical ownership of your health, this conversation will leave you fired up to turn struggle into strength.Dane Johnson is the Founder/CEO of Crohn's Colitis Lifestyle and a Holistic Nutritionist specializing in reversing Crohn's Disease and Ulcerative Colitis. Dane's story ignited through a life-threatening case of Crohn's/Colitis which nearly took his life December 2014. Since committing his life to natural healing he has remained surgery and medication-free while eliminating IBD symptoms. To date, Dane and his passionate team of specialists and coaches have created 500+ success stories for reversing IBD symptoms using his signature S.H.I.E.L.D. Program. His passion, unique experience, and niche in the field of IBD have empowered him to create unparalleled value for real, long-term symptom relief for those suffering from Inflammatory Bowel Disease.SHOW NOTES:0:39 Welcome to the podcast!1:50 Dane Johnson's Bio2:51 Welcome him to the show!3:58 Getting sick with IBD7:54 His turning point for getting results9:49 How to find the right IBD provider11:35 How to be the CEO of your health15:15 How to find hope18:03 Becoming resourceful & tracking symptoms23:19 The Success Tracker28:32 Supplement caution30:55 His checklist for IBD32:44 What is Glyphosate39:42 Rebuilding your microbiome & gut lining42:18 Nervous system support46:50 Listening to intuition51:58 Correlative issues with IBD53:52 Tips for supporting the gut59:05 Where to find him1:01:35 Thanks for tuning in!RESOURCES:Website: Crohn's Colitis LifestyleIG: Dane JohnsonIG: CCLS.H.I.E.L.D. ProgramHealing JournalIBD Strategy SessionSupport this podcast at — https://redcircle.com/biohacker-babes-podcast/donationsAdvertising Inquiries: https://redcircle.com/brands

Episode Summary Sue Ishaq, Ph.D., Associate Professor of Microbiomes at the University of Maine, discusses how gut microbes transform seemingly inert plant compounds—like glucosinolates found in broccoli—into powerful anti-inflammatory agents such as sulforaphane. Her research dives into the fascinating interplay between diet, cooking methods and the diversity of the gut microbiota, revealing how these factors influence the body's ability to produce health-promoting molecules. Links for This Episode mSystems paper: Early life exposure to broccoli sprouts confers stronger protection against enterocolitis development in an immunological mouse model of inflammatory bowel disease. mSystems paper:  Steamed broccoli sprouts alleviate DSS-induced inflammation and retain gut microbial biogeography in mice. Current Developments in Nutrition paper: Current knowledge on the preparation and benefits of cruciferous vegetables as relates to in vitro, in vivo, and clinical models of Inflammatory Bowel Disease.

Send us a textA boxer in training. A terrifying spiral of symptoms. A life-saving surgery that changed everything. Jose Torres joins us to share how ulcerative colitis pulled him out of the ring and propelled him into purpose—building community, advancing equity, and living well with a J‑pouch in a city that isn't designed for urgent needs.We trace Jose's path from misdiagnosis in Brooklyn to specialized care in Manhattan and the brutal logistics of public transit without bathrooms. He opens up about the cultural currents in his Mexican and Puerto Rican family—why speaking up took time, why steroids raised tough questions, and how food traditions collided with new IBD realities. The story turns on resilience: a colectomy and J‑pouch, early pouchitis, iron infusions, and then a decade of medication-free stability supported by smart nutrition, consistent exercise, and honest attention to mental health.Jose also brings us inside the Crohn's & Colitis Foundation—from literally ringing the office doorbell to roles in advancement, business development, and DEI leadership. We talk about real lived experience, research into disparities, and why culturally fluent care changes outcomes. Along the way, he shares practical tactics for managing frequency, a nudge toward pelvic floor physical therapy, and a grounded philosophy: don't chase perfection, cultivate accountability and hope.If stories of grit, culture, and community help you feel less alone with IBD, this one's for you. Cheers!Links: Camp Oasis- Crohn's & Colitis Foundation USACamp Purple- Crohn's & Colitis Foundation New ZealandAbout IBD podcast with Amber Tresca episode- "IBD in the Hispanic Community with Dr. Oriana Damas"Let's get social!!Follow us on Instagram!Follow us on Facebook!Follow us on Twitter!

Update your approach to the evaluation and management of IBD with Dr. Aline Charabaty (@DCharabaty). Review updates in management options, imaging modalities and preventive health recommendations.  Claim CME for this episode at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments Intro Case Initial presentation and evaluation  Imaging and endoscopic findings  Treatment options  Treatment goals Diet Recommendations Preventive Health Vitamin Deficiencies  Flare evaluation Inpatient care  Credits Written and Produced by: Elena Gibson MD  Infographic and Cover Art:Elena Gibson MD  Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP    Reviewer: Emi Okamoto MD Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Aline Charabaty MD, FACG, AGAF Disclosures Dr. Charabaty reports no relevant financial disclosures. The Curbsiders report no relevant financial disclosures.  Sponsor: Quince  Go to Quince.com/curb for free shipping on your order and 365-day returns. Now available in Canada, too. Sponsor: Freed Use code: CURB50 to get $50 off your first month when you subscribe! Sponsor: Permanente Medical Group Discover more at northerncalifornia.permanente.org

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're delving into a series of fascinating updates that underscore a period of significant scientific advancement, strategic partnerships, and regulatory developments in the industry.Starting with Dianthus Therapeutics, which has taken a bold step by investing up to $1 billion to license a bifunctional fusion protein from Nanjing Leads Biolabs. This protein targets autoimmune disorders, a field of immense interest due to the unmet medical needs and potential for breakthrough treatments. Such substantial financial commitments highlight the ongoing trend in the biotech sector towards innovative therapies for autoimmune diseases. In parallel, Sanofi has secured a $500 million agreement with Evoq Therapeutics, continuing its strategic focus on next-generation autoimmune technologies. This partnership aligns with Sanofi's broader strategy to leverage cutting-edge science in managing autoimmune conditions more effectively. Sanofi's engagement with Evoq Therapeutics stands out as a significant step forward in conquering autoimmune diseases through nanodisc technology designed to facilitate the development of curative treatments for disorders like celiac disease and type 1 diabetes. This collaboration reflects a growing trend among pharmaceutical giants investing in advanced biotechnologies that promise transformative impacts on disease management and patient care.Meanwhile, AstraZeneca's renewed collaboration with Immunai, valued at $85 million, seeks to enhance therapies for inflammatory bowel disease through artificial intelligence. This collaboration is part of a wider industry movement towards utilizing AI in drug discovery and development, particularly for complex diseases like IBD. AI's ability to process large datasets and identify potential therapeutic targets faster and more accurately is revolutionizing how companies approach drug development.In clinical trial news, Praxis Precision Medicines has reported positive Phase 3 results for ulixacaltamide in treating essential tremor. This outcome reverses prior concerns from interim analyses and illustrates the persistent innovation in neurological disorder treatments. Similarly, AiCuris has announced successful results from its Phase 3 trial of pritelivir for refractory herpes simplex virus infections in immunocompromised patients. This success paves the way for an FDA filing, demonstrating ongoing progress in antiviral therapy development.Novartis is also making strides with favorable outcomes from its Phase 3 trial of fabhalta for IgA nephropathy. As a complement factor B inhibitor, fabhalta has shown efficacy in slowing kidney function decline, which may lead to a new standard of care for this chronic kidney disease. Novartis plans to file these findings with regulatory bodies soon, highlighting its strategic focus on diversifying into rare kidney diseases.Turning to industry trends, there is significant investment activity in antibody-drug conjugates (ADCs). French biotech company ADCytherix has raised $122 million to advance these targeted therapies into clinical trials. ADCs are gaining traction due to their precision in targeting cancer cells while minimizing damage to healthy tissues. Such advancements signal a potential shift in cancer treatment paradigms toward more targeted and less toxic therapies. Similarly, Tubulis raised an impressive Series C funding round to advance work on ADCs targeting ovarian and lung cancers, underscoring the growing interest in the potential of ADCs engineered to deliver cytotoxic drugs specifically to cancer cells.In another intriguing development, research has shown that a common diabetes drug can alleviate brain inflammation in female mice with multiple sclerosis. This finding exemplifies the growing interest in drug repurposSupport the show

Could your fatigue, bloating, or random skin rashes be more than “just stress” or IBS? You might be shocked to learn they could actually be signs of inflammatory bowel disease (IBD) or even colon cancer — yes, it's possible without having obvious digestive symptoms.It's unfortunately common to discover that you have Crohn's or ulcerative colitis in your 60s, and not because of gut issues… but during a routine colonoscopy screening. Others are misdiagnosed for years while battling brain fog, thyroid problems, skin issues like psoriasis, vitiligo, eczema, or even unexplained anemia — all while the real problem quietly worsens.I'm joined by Dr. Ilana Gurevich, a naturopathic gastroenterologist who specializes in complex GI disorders. We dive into the hidden signs of IBD, how it differs from IBS, sneaky signs of colon cancer (especially with skyrocketing rates), and the TRUTH about colonoscopies – why you should absolutely stop putting it off and never use a stool test for gut health as a replacement.If you've been brushed off, gaslit, or still searching for answers, you don't want to miss this.⭐️Mentioned in This Episode:- See all the references

This year's Nobel Prize in Physiology or Medicine has been awarded for discoveries that explain how the immune system attacks hostile infections, but not the body's own cells. We explain the science that won Japan's Shimon Sakaguchi and US researchers Mary Brunkow and Fred Ramsdell the prestigious award.How robots can help children with reading anxiety. Lauren Wright from the University of Chicago who led this research explains.A new targeted antibiotic has been found that treats Inflammatory Bowel Disease. Dr Graham Easton who is Professor of Clinical Communication Skills at Queen Mary University of London describes how it works.Missing your first mammogram appointment has as much impact on breast cancer outcomes than an inherited genetic risk according to new research. Ziyan Ma from the Department of Medical Epidemiology and Biostatistics at the Karolinska Institute tells us more.And should we reconsider how we treat blood pressure? Presenter: Claudia Hammond Producer: Katie Tomsett

Send us a textImagine being able to turn down the volume on gut pain, food fear, and medical anxiety—without white-knuckle coping or guesswork. We sit down with Dr. Ali Navidi, co-founder of GIpsychology.com and past president of the Northern Virginia Society of Clinical Hypnosis, to unpack how clinical hypnosis and gut-focused CBT help people with inflammatory bowel disease interrupt the gut-brain loop that keeps symptoms alive. No stage tricks here—just practical tools that retrain the nervous system, reduce visceral hypersensitivity, and restore a sense of control.We explore the real differences between stage and clinical hypnosis and why trance is a natural state you already know how to access. Dr. Navidi explains how anchors—a simple conditioned cue—can trigger a calming response within seconds, whether you're prepping for a colonoscopy, calling the insurance company, or navigating an unexpected flare. We dig into disorders of gut-brain interaction (DGBIs) that can drive symptoms even when labs look great, and why gut-focused CBT plus hypnosis outperforms one-size-fits-all mental health approaches for persistent GI distress.Trauma and nocebo effects show up in subtle ways across the IBD journey. We get candid about medical trauma, memory reconsolidation, EMDR as a hypnotic protocol, and how conditioned food sensitivities form—like the “pizza panic” that lingers long after a flare. You'll hear how to calm hypervigilance, rebuild trust with your body, and reintroduce foods safely. We also share details on a new eight-week telehealth group, created with the Crohn's & Colitis Foundation and the American College of Gastroenterology, that pairs weekly skills training with recorded hypnosis sessions for daily practice.Ready to try tools that actually change how your system reacts? Follow, share with a friend who needs hope, and leave a review to help others find the show. Your story might be the anchor someone else needs today.Links: Information about the IBD Psychotherapy GroupInformation on Disorder of the Gut-Brain Interaction (DGBI)Great resources from GI PsychologyArticle in the AtlanticDr. Navidi on the About IBD Podcast with Amber TrescaLet's get social!!Follow us on Instagram!Follow us on Facebook!Follow us on Twitter!

Drs Rubin and Bedell discuss mental health impacts in inflammatory bowel disease (IBD) and how to address them. Credit available for this activity expires: 10/07/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/inflammatory-bowel-disease-why-mental-health-and-wellness-2025a1000q8p?ecd=bdc_podcast_libsyn_mscpedu

Abbott Elementary star Tyler James Williams' Crohn's disease battle, Madonna's bacterial infection ICU experience, and Breast Cancer myths lead our next Medical Mondays live. We'll run Myth vs. Fact to kick off Breast Cancer Awareness Month

My most recent coronary calcium score is 1200. What are your recommendations?My husband has been sweating like crazy during our walks. What may be causing this?How serious is RSV for seniors? What about healthy seniors?

The secrets of the world's oldest woman at 117: The microbiome and good genes as determinants of longevityWhat are your thoughts on plasmalogens?Our 24-year-old son has recently been diagnosed with Crohn's disease - help! 

What happens when physicians and advanced practice providers (APPs) truly work as a team in managing inflammatory bowel disease (IBD)? In this episode, we're joined by Dr. Jennifer Seminerio, Director of Inflammatory Bowel Disease and Associate Professor of Medicine, and Megan Pearce, DNP, APRN, FNP-C, from the AdventHealth IBD Clinic in Orlando, FL. Together, they share how collaborative APP/MD relationships enhance patient trust, streamline care, and support shared decision-making for those living with Crohn's disease and ulcerative colitis. We'll explore: How APP/MD teamwork improves patient experiences Practical tips to get the most out of clinic visits Ways to navigate complex treatment decisions together Dr. Seminerio and Megan also highlight the inaugural AdventHealth Crohn's and Colitis Patient Education Conference, presented by the AdventHealth IBD Program, happening Saturday, October 11, 2025, at the Renaissance Orlando at SeaWorld®. This event will bring together patients, caregivers, and experts to share education, support, and community for all impacted by IBD.

Did you know that you can heal ulcerative colitis and Crohn's disease using natural supplements and diet? In this episode, I've compiled the top treatments proven to improve these autoimmune conditions, also known as inflammatory bowel disease (IBD), all backed by the latest in health research.    ✅Start healing with us! Learn more about our virtual clinic: https://drruscio.com/virtual-clinic/  

In this special sponsored episode from Takeda, Angelina Collins, a Nurse Practitioner at a large tertiary inflammatory bowel disease (IBD) center in California, shares insights from her nearly two-decade journey in IBD care. She explores the challenges of diagnosing Crohn's disease and ulcerative colitis, from varied symptom presentation to limitations in early recognition. Emphasizing the potential consequences of delayed diagnosis—including disease progression and increased risk of complications—Angelina advocates for early identification of red flags and a multidisciplinary team approach to treatment and care. She highlights the critical role of advanced practice providers and the importance of expanding IBD knowledge across health care teams. Listeners will come away with insights on how to recognize red flags, apply best practices for timely referrals, and leverage collaborative care models in IBD management. READ THE ARTICLE → https://kevinmd.com/takeda Are you a health care clinician looking to increase your IBD knowledge? Visit IBDIQ.com, part of The IBD Project, to continue to evolve your IBD knowledge for yourself and your patients. Developed by Takeda in collaboration with IBD specialists and created for health care providers, IBDIQ is an on-demand educational platform, available at no cost, that offers timely, relevant information tailored to today's IBD care landscape: https://www.ibdiq.com/ Please note, no continuing medical education credits are offered through IBDIQ. VISIT SPONSOR → https://www.ibdiq.com/ SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast

The cause of autism revealed—is it Tylenol? Is there an ideal probiotic for Crohn's Disease? Treating constipation by modifying the microbiome with botanicals; ACTION ALERT: If Congress has its way, 95% of natural hemp products with CBD/THC may be banned by year's end! The popular diet that reverses psoriasis; A daily habit that could save you from chronic back pain.

People with dementia who develop inflammatory bowel disease (IBD) show faster deterioration in thinking, memory, and reasoning skills A large-scale analysis of 7.9 million participants revealed IBD patients face significantly elevated dementia risk, with Crohn's disease showing stronger association than ulcerative colitis IBD triggers systemic inflammation, releasing cytokines that breach the blood-brain barrier, disrupting neural communication and contributing to progressive neurodegeneration over time IBD creates gut dysbiosis, producing neurotoxic metabolites, and increasing intestinal permeability, allowing harmful substances to reach the brain through bloodstream circulation Supporting cellular health through vegetable oil elimination, proper carbohydrates, targeted probiotics, vitamin D optimization, and natural antimicrobials can address IBD's root causes

Send us a textComedian Ian Goldstein takes us through his journey with Crohn's disease, beginning with his diagnosis at 16 when he was just trying to navigate the already challenging world of high school, SATs, and planning for college. With candid humor, he recounts the moment he realized something was seriously wrong – not just from frequent bathroom trips, but when a coworker pointed out his dramatic weight loss.What follows is a rollercoaster of medical experiences that many in the IBD community will recognize – from the shock of needing a colonoscopy as a teenager to the trial and error of finding effective medications. Ian vividly describes his first major bowel obstruction during his senior year of college, complete with what he calls the "modern-day torture device" known as an NG tube. Despite his best efforts to manage his condition through diet alone, he eventually required surgery in 2022 to remove seven strictures from his small intestine.The conversation takes a fascinating turn when Ian shares how he's transformed his medical journey into comedy shows. From "The Autoimmune Saloon" to a celebration party for meeting his healthcare deductible (complete with custom cupcakes and hats), he's found ways to create community while addressing serious issues like medical debt. These creative outlets not only helped him process his experiences but connected him with others who could offer crucial advice about doctors and treatments.Perhaps most valuable are Ian's insights about navigating the healthcare system with a chronic illness. He speaks honestly about the frustration of insurance denials, the anxiety of unexpected medical bills, and the challenges of having an invisible disability. His experiences highlight the importance of self-advocacy, finding the right medical team, and building a supportive community.Ready to laugh, cry, and feel a little less alone in your IBD journey? Listen as Ian shares his practical wisdom: record your doctor appointments to remember important information, and seek out community connections that might literally change your life. Whether you're newly diagnosed or a veteran of chronic illness, this conversation reminds us all that finding humor in dark places might be our most powerful medicine.Links: Ian's websiteNew York Times article about Ian's party to celebrate meeting his healthcare deductibleThe Squeaky Wheel- satire publication that focuses on the experiences of people living with disabilities. Tina's episode with usDr. David Schwartzberg's episode with usNicole's episode with us- Ian mentioned Nicole and how supportive she's been to him but we sadly had to cut that part out for length. But- get to know Nicole!! Let's get social!!Follow us on Instagram!Follow us on Facebook!Follow us on Twitter!

Living with Inflammatory Bowel Disease (IBD) means encountering life-changing challenges, but it doesn't have to define your future. Jannine Purcell, CNP, Gastroenterology, discusses how IBD affects young adults in their 20s and 30s, often disrupting major life milestones. Jannine explains the difference between Crohn's disease and ulcerative colitis and why team-based care is essential. She shares inspiring success stories of patients who've achieved deep remission and provides insight into why close follow-up and patient education are crucial for helping young people reclaim their quality of life. Hosted on Acast. See acast.com/privacy for more information.

Send us a textIn this inspiring episode of the IBS Nutrition Podcast, dietitian Jessie Wong sits down with Lauren, a former client who struggled with both IBS and microscopic colitis, a form of Inflammatory Bowel Disease. After years of symptoms like diarrhea, urgency, bloating, and food anxiety, Lauren found lasting relief through the IBS Freedom Program.You'll hear how Lauren went from trying elimination diets, food fear, and naturopathic treatments (SIBO Protocol & herbal supplements) to working with GI specialists and dietitians who finally helped her get the right diagnosis. With expert guidance, personalized food tracking, and targeted reintroductions, she's now symptom-free — and no longer fears leaving the house.In This Episode, You'll Learn:✔️ Lauren's experience navigating IBS, microscopic colitis (IBD), and SIBO✔️ Why restrictive elimination diets and herbal supplements weren't the solution✔️ How food tracking and journaling revealed hidden triggers✔️ The difference between raw vs. cooked onions and garlic for IBS symptoms✔️ How the IBS Freedom Program restored her food freedom and quality of life✔️ Lifestyle tools that reduced anxiety, improved bowel habits, and stopped flare-ups✔️ Lauren's advice for people with IBS who feel stuck after years of guessworkTimestamps:[00:00] Intro & IBS Freedom Program details[03:03] Microscopic colitis diagnosis after years of misdiagnosis[06:36] GI appointment frustration and lack of support[07:35] What made the IBS Freedom Program different[10:24] Food challenges and safe reintroduction[13:37] Why you shouldn't cut FODMAPs forever[15:42] Lifestyle challenges that helped reduce IBS anxiety[18:17] Cutting back on supplements safely[21:16] Lauren's advice: be patient, work with professionals[21:46] 1-year transformation: from stuck at home to symptom-freeGet our help:

In this episode, I'm joined by Dr Gina Trakman, course coordinator of La Trobe University's Master of Dietetics and research dietitian with expertise in Inflammatory Bowel Disease and Sports Nutrition. Gina shares her insights from leading international research on diet, gut microbiota, and Crohn's disease, and breaks down how food can influence inflammation and symptom management. We'll explore common misconceptions, practical strategies for navigating flares and remission, and the role of personalised nutrition in IBD care. Whether you live with IBD, support someone who does, or are simply curious about gut health, this conversation offers evidence-based and practical guidance for everyday life. So whether you're curious, concerned or just keen to learn more, this episode is full of insights you won't want to miss. Please enjoy my conversation with Dr Gina Trakman.

Send us a textImagine visiting your gastroenterologist and feeling comfortable enough to discuss every aspect of how IBD affects your life—including your sexual health and practices. For many patients, particularly those in the LGBTQI+ community, this remains an elusive dream rather than reality.Dr. Victor Chedid, gastroenterologist and director of Mayo Clinic's Pride Clinic, joins Bowel Moments to tackle this crucial gap in IBD care. With disarming honesty and clinical expertise, he reveals why addressing sexuality isn't just about inclusivity—it's about providing complete medical care. When 95% of providers believe discussing sexual health is important but only 27% actually do it, patients suffer in silence with questions that directly impact their quality of life.The conversation dives deep into practical approaches for both patients and providers. Dr. Chedid shares his framework for discussing sexual practices with patients, from the straightforward question "What do you do for sex?" to navigating complex conversations around surgical interventions like J-pouch formation. For transgender patients, he unpacks recent research on gender-affirming hormones and IBD, emphasizing that life-saving gender-affirming care should never be withheld due to IBD concerns.Perhaps most compelling is Dr. Chedid's perspective on cultural humility and intersectionality. Each patient's experience is shaped by multiple overlapping identities—their sexuality, gender, race, nationality, and more. Rather than making assumptions, he advocates for providers to "leave their biases at the door" and approach each person's unique situation with curiosity and respect."People living with IBD are the experts of their own bodies," Dr. Chedid reminds us in his powerful closing thoughts. "When they say something feels off, it's not a guess—it's lived experience." This principle forms the foundation of truly inclusive care—care that sees patients as whole people deserving of dignity, understanding, and comprehensive treatment.Ready to advocate for more inclusive IBD care? Share this episode with your healthcare team and join the conversation about creating safe spaces for everyone in our community.Links: AGA's Pride Month Provider Spotlight on Dr. ChedidDr. Chedid talking about forming the IBD Pride Clinic"Your Top 6 Questions Answered by Dr. Victor Chedid" -A Program Dedicated to IBD Patients from the LGBTQIA+ Community- Crohn's & Colitis Foundation- USALet's get social!!Follow us on Instagram!Follow us on Facebook!Follow us on Twitter!

Send us a textFor two decades, Rachel Gebhardt has navigated the complex terrain of Crohn's disease with a refreshing perspective shaped by her father's experience with the same condition. Where her father let illness define him, Rachel chose a different path—one filled with humor, openness, and resilience—despite her case being more medically severe.Rachel's journey encompasses four bowel surgeries and fourteen hospital admissions since 2020 alone, including a colostomy she affectionately named "Whoopie." With disarming candor, she shares the moment her surgeon showed her a photo of a woman in an American flag bikini with a matching ostomy bag cover as encouragement—a moment that eventually inspired her own celebratory beachside photo years later. Through skin infections, bowel obstructions, and dietary restrictions, Rachel maintains her commitment to living fully and modeling positive coping for her children.The military healthcare system presented unique challenges, but also connected Rachel with Dr. Anish Patel at Brook Army Medical Center, who became not just her gastroenterologist but her advocate and ally. Their relationship exemplifies the profound difference compassionate, specialized care makes for patients with complex conditions. Rachel details her experience with hyperbaric treatments, medication complications, and the surprising remission she experienced only during pregnancy and breastfeeding—highlighting the understudied connection between hormones and IBD.What resonates most deeply is Rachel's transformation from initially viewing her ostomy as "the end of the world" to embracing it as a source of freedom. Now training for a half marathon and hiking mountains previously inaccessible when bathroom urgency controlled her life, she's become an outspoken advocate for ostomy awareness. Her message is clear and powerful: life with an ostomy can be not just manageable, but genuinely good—a perspective desperately needed by those facing similar paths. For anyone navigating IBD or supporting someone who is, Rachel's story offers both practical wisdom and heartening hope.Links: United Ostomy AssociationOur episode with Dr. Anish PatelPregnancy and Crohn's - video from Brigham & Women's IBD CenterPregnancy & Breastfeeding info- Crohn's Colitis UKLet's get social!!Follow us on Instagram!Follow us on Facebook!Follow us on Twitter!

Send us a textWhat happens when your body declares war on multiple organs? Julie Davis knows this reality all too well. Her medical journey began with a celiac disease diagnosis at 18, followed by ulcerative colitis in college, but it was the sudden onset of autoimmune pancreatitis in 2011 that turned her world upside down.Julie's story is remarkable not just for the rare combination of conditions she manages, but for the extraordinary resilience she's shown throughout her journey. As a dietitian who became a physician's assistant while battling debilitating pancreatitis flares, Julie brings unique perspective from both sides of healthcare. She takes us through the harrowing experience of multiple hospitalizations, specialists puzzling over her case at Mayo Clinic, and ultimately, the life-altering decision to have her pancreas completely removed in 2023.The procedure—called total pancreatectomy with islet cell autotransplantation—is so rare that Julie couldn't find a single podcast about it. Her pancreatic cells were extracted and transplanted into her liver, turning her into what she describes as "essentially a type 1 diabetic" overnight. Despite this dramatic medical intervention and the insulin pump she now relies on, Julie's perspective remains incredibly positive.Perhaps most inspiring is how Julie has refused to let her health conditions define her limitations. She completed PA school despite having an endoscopy and nerve block the same morning as important exams. She had three children through IVF while managing multiple autoimmune conditions. And today, she's passing on her hard-won wisdom to her daughter, who has inherited celiac disease.Julie's message to fellow chronic illness warriors rings clear: "It doesn't define you. You can still do things that you love." Her extraordinary journey demonstrates that even the most complex medical challenges can't stand in the way of a determined spirit pursuing a fulfilling career, family life, and future.Links: The Juicebox PodcastMission Cure: Nonprofit working in improve quality of life and bring more treatments to chronic pancreatitis Let's get social!!Follow us on Instagram!Follow us on Facebook!Follow us on Twitter!

Send us a text** Warning that this episode talks very candidly and descriptively about surgery and more.** Few IBD stories contain as many twists, complications, and near-death experiences as Bryan Schulze's journey with ulcerative colitis. What began with occasional bleeding during his military deployment escalated into a life-threatening medical emergency when doctors discovered he had been hemorrhaging internally for months. With severe anemia and barely conscious, Bryan's introduction to IBD came with a stark realization — he had been slowly dying without knowing it.Bryan's candid account takes us through the harrowing reality of military service with undiagnosed IBD, the struggle to maintain dignity while bleeding profusely, and the complex surgeries that followed. After medication failures and complications that defy belief, Bryan underwent a full colectomy and J-pouch surgery that led to severe complications including a massive abdominal infection, wound vacuum treatments, and catastrophic surgical errors. Beyond the physical trauma, Bryan shares the emotional and professional toll of IBD. From workplace discrimination to failed career dreams, steroid-induced diabetes to heart failure, and battles with depression and anxiety — his story encompasses the full spectrum of challenges IBD patients may face. Yet through it all, Bryan found his way back through support from his family, reconnection with his faith, and an indomitable will to live.Now serving as a police officer with a permanent ostomy bag, Bryan offers powerful wisdom to fellow IBD warriors: "Take a deep breath. It's not a life ender. It is a life changer. Be willing to adapt with it so that you can overcome it and still live the life that you were given to live." His message of resilience serves as a beacon for anyone facing seemingly insurmountable health challenges.Have you been struggling with IBD? Share your story or questions with us, and remember that no matter how difficult your journey, you're never alone in this fight.Links: Our episode with Dr. Anish PatelOur episode with Matty Bowels! Veterans with IBD Support Group- Cron's & Colitis Foundation USAAbout IBD Podcast episode with Dr. Anish PatelJohn's story of serving in the Royal Marines in the UK- Crohn's & Colitis UIKLet's get social!!Follow us on Instagram!Follow us on Facebook!Follow us on Twitter!

In this episode of Bowel Sounds Summer School, hosts Drs. Temara Hajjat and Jason Silverman have taken highlights from past episodes on inflammatory bowel disease (IBD) and put them into a special episode jam-packed with clinical pearls. Former expert guests explain how to manage patients with IBD. Our Bowel Sounds Summer School series will include 4 episodes each summer on big topics in our field, artisanally crafted for the ears of listeners of all stages, from the young student to the seasoned attending.Learning ObjectivesReview the epidemiology of IBD.Review the management of Crohn's and ulcerative colitis,  either medication, dietary, or surgery. Reviewing treatment goals, such as therapeutic drug monitoring (TDM) and treat-to-target. Review VEOIBD, US in IBD, Puberty and Pregnancy in IBD. Support the showThis episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Check out our merch website!Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.Click here to support the show.

Host: Darryl S. Chutka, M.D. Guest: Sunanda V. Kane, M.D. Most people who develop inflammatory bowel disease are diagnosed before the age of 30. In women, this often occurs during the middle of their reproductive years. Some with inflammatory bowel disease choose to avoid pregnancy, usually due to misconceptions about pregnancy risks. Yet if properly managed, women can experience a normal, uneventful pregnancy and deliver a healthy child.  What effect does inflammatory bowel disease have on fertility? Do patients have a greater chance of a normal pregnancy if the bowel disease is in remission? How can patients minimize the risk of inflammatory bowel disease flares during pregnancy and are the pharmacologic therapies commonly used to treat inflammatory bowel disease safe to use during pregnancy? These are some of the questions I'll ask my guest, Sunanda V. Kane, M.D., from the Division of Gastroenterology and Hepatology at the Mayo Clinic as we discuss “Inflammatory Bowel Disease and Pregnancy”. https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

Host: Darryl S. Chutka, M.D. Guests: Amanda M. Johnson, M.D., and Victor G. Chedid, M.D., M.S. This podcast continues our series on inflammatory bowel disease. The topic is important and timely: “Inflammatory Bowel Disease in Special Populations: The Elderly, the Obese and the LGBTQ Patient.” It's critical that we broaden our perspective in addressing the unique challenges faced by these often-unrecognized population groups. How common is the presentation of inflammatory bowel disease in those over 65? How does age affect the treatments commonly used? Does obesity alter the disease presentation or activity and what are some of the unique challenges our LGBTQ patients face with inflammatory bowel disease? These are just some of the questions I'll be asking my guests, Amanda M. Johnson, M.D., and Victor G. Chedid, M.D., M.S., both gastroenterologists at the Mayo Clinic. https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

Host: Darryl S. Chutka, M.D. Guest: Konstantinos A. Papadakis, M.D. Due to the complexity and new pharmacologic options for the management of inflammatory bowel disease, patients often have their care provided by a gastroenterologist. They may not see their primary care provider as often as in the past and some of their preventive health maintenance may not get performed. Are patients receiving primarily specialty care still receiving good health maintenance?  Are we aware that patients with inflammatory bowel disease have some unique needs regarding their preventive health maintenance and some of the recommendations are different than the general population? These are questions I'll be asking my guest, gastroenterologist Konstantinos A. Papadakis, M.D., from the Mayo Clinic as we discuss “Health Maintenance in Inflammatory Bowel Disease” as part of our ongoing series on Inflammatory Bowel Disease. https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

Host: Darryl S. Chutka, M.D. Guests: Darrell S. Pardi, M.D., and Laura E. Raffals, M.D. Pouchitis is a relatively common complication in patients who have ulcerative colitis and have had a proctocolectomy with an ileal pouch-anal anastomosis. It represents inflammation of the ileal pouch and symptoms may include increased stool frequency, cramps, fecal urgency and occasionally bloody stools. The diagnosis is usually suspected from clinical symptoms and confirmed with endoscopy. Are there risk factors for the development of pouchitis? Is an endoscopy necessary for a diagnosis? How should patients be treated and how effective is treatment? These are some of the questions I'll be asking my guests, Darrell S. Pardi, M.D., and Laura E. Raffals, M.D., both gastroenterologists at the Mayo Clinic. We'll be discussing “Pouchitis” as part of our podcast series on “Inflammatory Bowel Disease”. https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

Host: Darryl S. Chutka, M.D. Guests: Darrell S. Pardi, M.D., and Laura E. Raffals, M.D. Microscopic colitis is one of the lesser-known members of the inflammatory bowel disease family. Symptoms include chronic, frequent diarrhea and fecal urgency. It's usually suspected from the patient's clinical symptoms and diagnosis is established by colonoscopy with biopsy. Biopsy is necessary as the colonic mucosa appears normal at endoscopy. A specific cause isn't known but it can be associated with several medications. Although it's not typically a life-threatening condition, it can lead to weight loss and potentially dehydration. How does microscopic colitis differ from ulcerative colitis or Crohn's Disease? Who's at risk of developing it? Since these patients usually present to primary care providers, when should we suspect it? How is it managed, and can it be cured?  These are some of the questions I'll be asking my guests, Darrell S. Pardi, M.D., and Laura E. Raffals, M.D., both gastroenterologists at the Mayo Clinic. We'll be discussing “Microscopic Colitis” as part of our ongoing series of podcasts on “Inflammatory Bowel Disease”. https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts